Form D · Pharmaceuticals

SapVax, LLC

Cleveland, OH · CIK 0001694191

Offering snapshot reported Jan 15, 2019 · SEC filing

Reported sold
$3.25M
Offering amount: $5M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 5, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.63M$3.25MJan 18, 2017: $350,000.00Jan 18, 2017Jan 16, 2018: $3,237,300.00Jan 16, 2018Jan 15, 2019: $3,250,000.00Jan 15, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,237,300 → $3,250,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 15, 2019Amendment$3,250,000$12,700vs Jan 16, 20184SEC filing
Jan 16, 2018Amendment$3,237,300$2,887,300vs Jan 18, 20174SEC filing
Jan 18, 2017Initial$350,000No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-278682

Source: Form D, filed Jan 15, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Will Charles Director
Jeff Edelson Director
Baiju Shah Director, Executive
Terry Vance Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
20600 Chagrin Boulevard Suite 210
Cleveland, OH, 44122